The Big Phar­ma axe: Mer­ck cuts chikun­gun­ya vax, Bris­tol My­ers drops Cy­tomX-part­nered pro­gram, and more

As fourth quar­ter earn­ings come in, Big Phar­mas are dis­clos­ing changes to their pipelines dur­ing their in­vestor calls, and some­times more qui­et­ly in pre­sen­ta­tion ap­pen­dices …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER